Abbott Laboratories 2014 Annual Report Download - page 33

Download and view the complete annual report

Please find page 33 of the 2014 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

31
ABBOTT 2014 ANNUAL REPORT
PROJECTED GROWTH OF GROSS
DOMESTIC PRODUCT 20142019
EMERGING PHARMACEUTICAL
MARKETS ARE CONSUMER ORIENTED
NUMBER ONE
Abbott is the No. 1 pharmaceutical company in India,
Chile, Colombia, and Peru, and top five in Russia.
>1,500
products in our
portfolio
88
countries in which
we have commercial
presence
27 manufacturing sites
ensure reliable local supply 10 pharmaceutical
development sites
75%
self-pay 25%
third-party payers
Healthcare spending is 18 percent of
gross domestic product in the United States,
but just 6 percent, and rising, in fast-growing
emerging markets Given the choice, consumers opt for
brands they know and trust
TOTAL
DEVELOPED
MARKETS
+2.0%
TOTAL
EMERGING
MARKETS
+4.6%
LATIN
AMERICA
+3.4%
CHINA
+6.7%
REGIONAL
PORTFOLIOS GLOBAL
STRENGTH TRUSTED
BRANDS